Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

São Paulo 05403-010

4 studies enrolling now · 13 studies all time

What they study most

Deep Vein Thrombosis (DVT), Delayed Graft Function, Hemophilia A, Hemophilia B, Hypophosphatemic Rickets, Immunoglobulin A Nephropathy (IgAN), Indolent B-Cell Non-Hodgkin Lymphoma, Lupus Nephritis, Neuromyelitis Optica Spectrum Disorder, Nonalcoholic Steatohepatitis, Pre-Exposure Prophylaxis of HIV Infection, Pulmonary Embolism

Studies at this site

• Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs) — Recruiting now
• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
• Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder — Recruiting now
• A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL — Recruiting now
• X-linked Hypophosphatemia Disease Monitoring Program — Running, not enrolling
• Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Running, not enrolling
• Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A — Completed
• Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease — Completed
• Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) — Stopped early
• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) — Completed
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study) — Completed